Aruba

Dr. Tricia Gangoo-Dookhan, BS Pharmacy, Pharm D., CPh

Nova Southeastern University School of Pharmacy

Dr. Gangoo-Dookhan is a clinical pharmacist at Nova Southeastern University (NSU) ACORN SEED Center College of Pharmacy in the department of Pharmacy Practice. Dr. Gangoo-Dookhan received her Bachelor of Science Degree from St. John’s University and Health Sciences, NY in 1994. She then went on to pursue and successfully obtain honors with highest honors her Doctorate of Pharmacy degree at Nova Southeastern University in 2000. Dr. Gangoo-Dookhan has had the opportunity to practice in many settings, community retail and institutional pharmacy as well as owning and operating her independent community pharmacy. In 2012, she was named “Pharmacist of the Year” for Bi-Lo Pharmacy. During her time there, she was able to spearhead and implement both immunization and MTM programs for Miami, Broward, and West Palm Beach Counties. During 2005 to 2011, she was instrumental in developing a county-wide program to offer HIV medications to patients who could not afford them.

Dr. Gangoo-Dookhan is a certified APhA Immunization and MTM trainer, a certified American Heart Association basic life support trainer, and a licensed consultant pharmacist in Florida. She currently oversees the day to day operations and services provided by student pharmacists to primary care physician groups and accountable care organizations, such as medication therapy management, transitions of care and pharmacy related support.

Friday June 25, 2021

PHARMACY AN EVOLVING PROFESSION : TRENDS TAKING ROOT IN PHARMACY PRACTICE

ACPE # 0043-9999-21-024-L04-P

Objectives:

1.  Discuss the key components of a collaborative practice agreement

2. Review newly implemented statutes and updates regarding collaborative practice agreements

3.  Describe the role of the pharmacist in developing and implementing collaborative practice agreements

4. Discuss the key components of point-of-care testing

5.  Review statutes and updates regarding point-of-care testing

6.  Describe the role of the pharmacist in developing a test, treat and manage protocol

7.  Discuss credentialing and certification requirements for pharmacist to enter into collaborative practice agreements and test and treat protocols

8.  Discuss updates on Provider Status for pharmacists

9.  Outline the process for implementing a collaborative practice agreement, test and treat and pharmacogenomic business model within a community pharmacy

——————————————————————————————————————————————-

Saturday June 26, 2021

TRANSITIONS IN CARE: THE NEXTGEN PHARMACIST

ACPE # 0043-9999-20-030-L04-P

Objectives:

1.  Assess how population health and quality benchmark measures financially impact a medical organization.
2. Educate pharmacists on Current Procedural Technology (CPT) codes that can be used without provider status.
3. Describe how Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) can reduce health care costs and improve the quality of care.
4. Identify numerous areas in which pharmacists have affected patient outcomes and cost savings using population health data.
5. Discuss Medicare endorsed clinical programs that pharmacists can offer primary care provider using a financial pro format.

Sunday June 27, 2021 

AN UPDATE ON IMMUNIZATIONS

ACPE # 0043-9999-20-031-L06-P

Objectives:

1.  Review vaccine immunology.
2.  Provide an outline of various disease states and their conditions.
3.  Interpret statistics on these diseases in the United States.
4.  Describe vaccinations including side effects and contraindications.
5.  Identify target population for each vaccine.
6.  Recommend appropriate vaccination schedule for all populations.
7.  Review updates on the immunization schedule for 2019 and new vaccines.
8.  Debunk common myths about immunizations and tips to communicate effectively with patients regarding these misconceptions.
9.  Review the management of adverse events post vaccination.
10.  Explain vaccine storage and stability.